Beranda › Leukemia Limfoblastik Akut › New York
Uji klinis Leukemia Limfoblastik Akut di New York
32 studi untuk Leukemia Limfoblastik Akut mencari peserta di lokasi di New York.
Kota di New York
- New York City24 studi
- Queens6 studi
- The Bronx5 studi
- Rochester4 studi
- Buffalo4 studi
- Greenburgh4 studi
- New Rochelle3 studi
- Staten Island3 studi
Teks studi resmi (Bahasa Inggris)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Queens Hospital Center, Jamaica
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Stony Brook University Medical Center, Stony Brook
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
- Memorial Sloan Kettering Cancer Center, New York
Menerima pesertaFase 1
Usia 12 hingga 78 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT03802695A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
- Memorial Sloan Kettering Cancer Center -- Pediatrics, New York
Menerima pesertaFase 2
6 Months · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06514794Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children
- Columbia University Medical Center, New York
Menerima pesertaStudi observasional
4 Weeks – 18 Years · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06529575Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
- Montefiore Einstein Comprehensive Cancer Center, The Bronx
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06308588A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- Montefiore Medical Center, New York
Menerima pesertaFase 1/2
30 Days · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT04065399A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
- The Mount Sinai Hospital, New York
Menerima pesertaFase 1
Usia 0 hingga 18 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT06173518Cord Blood Transplant in Adults With Blood Cancers
- Memorial Sloan Kettering Cancer Center, New York
Menerima pesertaFase 2
Usia 21 hingga 65 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT05884333First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
- Memorial Sloan Kettering Cancer Center, New York
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT07586618The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Albany Medical Center, Albany
- Maimonides Medical Center, Brooklyn
- NYU Langone Hospital - Long Island, Mineola
- dan 7 lainnya
Menerima pesertaFase 1/2
Hingga usia 22 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT04726241A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia
- Memorial Sloan Kettering Cancer Commack - Suffolk (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- dan 1 lainnya
Menerima pesertaFase 2
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT07400029A Study of CTD402 in T-ALL/LBL Patients
- Memorial Sloan Kettering Cancer Center, New York
- Montefiore Einstein Comprehensive Cancer Center, The Bronx
Menerima pesertaFase 1/2
Usia 1 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT07070219MedSupport Intervention to Identify and Address Barriers to Pediatric Medication Adherence
- Roswell Park Cancer Institute, Buffalo
Menerima pesertaSukarelawan sehat diterima
Semua usia · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT06323044Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
- Research Site, New York
Menerima pesertaFase 1/2
Usia 16 ke atas · Semua jenis kelamin · Diperbarui 20 Jul 2026 · NCT07155226A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Roswell Park Cancer Institute, Buffalo
- North Shore University Hospital, Lake Sucess
- Cohen Children's Medical Center of New York, New Hyde
- dan 9 lainnya
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT01351545A Study of Revumenib and Mezigdomide in People With Leukemia
- Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- dan 1 lainnya
Menerima pesertaFase 1/2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 22 Jun 2026 · NCT07356154TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
- Memorial Sloan Kettering Cancer Center, New York
Menerima pesertaFase 1/2
Hingga usia 1 · Semua jenis kelamin · Diperbarui 3 Jun 2026 · NCT05848687European Prospective Investigation Into Childhood Cancer
- Columbia University Irving Medical Center, New York
Menerima pesertaStudi observasional
Usia 3 hingga 21 · Semua jenis kelamin · Diperbarui 2 Jun 2026 · NCT05375617Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park
- University of Rochester, Rochester
- Stony Brook University Medical Center, Stony Brook
- dan 1 lainnya
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 18 Mei 2026 · NCT01790152Cord Blood Transplantation in Children and Young Adults With Blood Cancer
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Menerima pesertaFase 2
Hingga usia 26 · Semua jenis kelamin · Diperbarui 14 Mei 2026 · NCT07566377A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
- Ascentage Investigative Site #1160, Stony Brook
- Ascentage Investigative Site #1151, The Bronx
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Apr 2026 · NCT06051409Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3
- Roswell Park Comprehensive Cancer Center, Buffalo
Menerima peserta
Usia 3 hingga 9 · Semua jenis kelamin · Diperbarui 23 Apr 2026 · NCT06074666Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)
- The Mt. Hope Family Center, Rochester
Menerima peserta
Usia 8 hingga 17 · Semua jenis kelamin · Diperbarui 8 Apr 2026 · NCT06956781A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Roswell Park Comprehensive Cancer Center, Buffalo
Menerima pesertaFase 1/2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 24 Mar 2026 · NCT04988555A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)
- University of Rochester Medical Center, Wilmot Cancer Center, Rochester
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Mar 2026 · NCT06207123A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- Memorial Sloan Kettering, New York
Menerima pesertaFase 2
Usia 18 hingga 66 · Semua jenis kelamin · Diperbarui 17 Mar 2026 · NCT06859424Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- Memorial Sloan Kettering Cancer Center, New York
Menerima pesertaFase 2
Usia 18 hingga 54 · Semua jenis kelamin · Diperbarui 17 Mar 2026 · NCT06918431A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)
- Memorial Sloan Kettering Cancer Suffolk-Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- dan 1 lainnya
Menerima pesertaFase 1
Usia 17 ke atas · Semua jenis kelamin · Diperbarui 10 Feb 2026 · NCT06287528Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL
- Memorial Sloan Kettering Cancer Center, New York
Menerima pesertaFase 1
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 8 Jan 2026 · NCT04872478A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors
- Columbia University Medical Center, New York
Menerima peserta
Usia 5 hingga 21 · Semua jenis kelamin · Diperbarui 7 Okt 2025 · NCT05963971Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
- Memorial Sloan Kettering Cancer Center, New York
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Apr 2025 · NCT06462365Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Children's Hospital New York-Presbyterian, New York
- Memorial Sloan Kettering Cancer Center, New York
Menerima pesertaFase 1
Usia 1 hingga 21 · Semua jenis kelamin · Diperbarui 6 Des 2024 · NCT05476770Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.